The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20070874: Odyssey Investment Partners Fund III, LP; Diamond Castle Partners IV, L.P.
20071011: Fenway Partners Capital Fund III, L.P.; Rick An
20071010: Pitney Bowes Inc.; Maplnfo Corporation
20071006: Rethmann AG & Co. KG; SHV Holdings N.V.
20071004: Lake Capital Partners II LP; Cornerstone Equity Investors IV, L.P.
20071001: Madison Dearborn Capital Partners V-A, L.P.; The Topps Company, Inc.
20071000: Gibraltar Industries, Inc.; The Employee Ownership Holding Company, Inc.
20070999: Vector Stealth Holdings II, L.L.C.; SafeNet, Inc.
20070994: Castlerigg International Limited; Madison Dearborn Capital Partners IV, L.P.
20070993: Francisco Partners II, L.P.; FX Solutions LLC
Thermo Electron Corporation, In the Matter of
The consent order settled charges that Thermo Electron Corporation’s proposed $12.8 billion acquisition of Fisher Scientific International, Inc. would harm competition in the U.S. market for high-performance centrifugal vacuum evaporators (CVEs). Thermo and Fisher are the only two significant suppliers of high-performance CVEs in the United States and the proposed transaction would eliminate the direct price, service, and innovation competition that exists between them. To settle the Commission’s charges, Thermo is required to divest Fisher’s Genevac division, which includes Fisher’s entire CVE business, within five months of the date the consent agreement was signed.